Trial Profile
AVASTIN First Line in Metastatic Renal Cancer
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Interferon alpha-2a
- Indications Renal cell carcinoma
- Focus Adverse reactions; Therapeutic Use
- Sponsors Roche
- 01 Feb 2019 Results published in the Anticancer Research
- 15 Dec 2015 New trial record